BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

815 related articles for article (PubMed ID: 12823724)

  • 21. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pattern of 5-1-1 and c100-3 only on hepatitis C virus (HCV) recombinant immunoblot assay does not reflect HCV infection in blood donors.
    Busch MP; Tobler L; Quan S; Wilber JC; Johnson P; Polito A; Steane E; Zola A; Bahl C; Nelles M
    Transfusion; 1993 Jan; 33(1):84-8. PubMed ID: 7678710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of indeterminate c22-3 reactivity in volunteer blood donors.
    Tobler LH; Busch MP; Wilber J; Dinello R; Quan S; Polito A; Kochesky R; Bahl C; Nelles M; Lee SR
    Transfusion; 1994 Feb; 34(2):130-4. PubMed ID: 8310482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yield of hepatitis C virus nucleic acid testing among antibody-reactive or confirmed-positive samples.
    Schmidt M; Weber M; Busch MP; Tobler LH; Phelps BH; Seifried E; Roth WK
    Transfusion; 2005 Jun; 45(6):1040-2. PubMed ID: 15935008
    [No Abstract]   [Full Text] [Related]  

  • 26. Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation.
    Watson J; Mulvihill MS; Cox ML; Rich L; Wolfe CR; Gray A; Hartwig MG
    Clin Transplant; 2019 Mar; 33(3):e13476. PubMed ID: 30609162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of the NucliSens Extractor in combination with the hepatitis C virus Cobas Amplicor 2.0 assay in four laboratories in the Netherlands utilizing nucleic acid amplification technology for blood screening.
    Cuijpers HT; Molijn MH; Bos HJ; Peeters AP; van der Poel CL; Lelie PN
    Vox Sang; 2001 Jul; 81(1):12-20. PubMed ID: 11520410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of HCV and HIV-1 antibody negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testing.
    Jarvis LM; Dow BC; Cleland A; Davidson F; Lycett C; Morris K; Webb B; Jordan A; Petrik J
    Vox Sang; 2005 Oct; 89(3):128-34. PubMed ID: 16146504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative analysis of triplex nucleic acid test assays in United States blood donors.
    Stramer SL; Krysztof DE; Brodsky JP; Fickett TA; Reynolds B; Dodd RY; Kleinman SH
    Transfusion; 2013 Oct; 53(10 Pt 2):2525-37. PubMed ID: 23550838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The significance of third-generation HCV RIBA-indeterminate, RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassays.
    Kiely P; Kay D; Parker S; Piscitelli L
    Transfusion; 2004 Mar; 44(3):349-58. PubMed ID: 14996191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening.
    Jongerius JM; Sjerps M; Cuijpers HT; van Drimmelen HA; van der Poel CL; Reesink HW; Molijn MH; Peeters GA; Peeters TP; Lelie PN
    Transfusion; 2002 Jun; 42(6):792-7. PubMed ID: 12147034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
    Stramer SL; Glynn SA; Kleinman SH; Strong DM; Caglioti S; Wright DJ; Dodd RY; Busch MP;
    N Engl J Med; 2004 Aug; 351(8):760-8. PubMed ID: 15317889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China.
    Shang G; Yan Y; Yang B; Shao C; Wang F; Li Q; Seed CR
    Transfus Apher Sci; 2009 Aug; 41(1):3-7. PubMed ID: 19487161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pilot study on screening blood donors with individual-donation nucleic acid testing in China.
    Dong J; Wu Y; Zhu H; Li G; Lv M; Wu D; Li X; Zhu F; Lv H
    Blood Transfus; 2014 Apr; 12(2):172-9. PubMed ID: 24333061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seronegative hepatitis C virus infection in Polish blood donors-Virological characteristics of index donations and follow-up observations.
    Grabarczyk P; Kubicka-Russel D; Kopacz A; Liszewski G; Sulkowska E; Zwolińska P; Madaliński K; Marek M; Szabelewska M; Świątek E; Laskus T; Radkowski M
    J Med Virol; 2020 Mar; 92(3):339-347. PubMed ID: 31670401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations.
    Bamaga MS; Bokhari FF; Aboud AM; Al-Malki M; Alenzi FQ
    Saudi Med J; 2006 Jun; 27(6):781-7. PubMed ID: 16758035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving the safety of blood transfusion by using a combination of two screening assays for hepatitis C virus.
    Zhang K; Wang L; Sun Y; Zhang R; Lin G; Xie J; Li J
    Transfus Med; 2014 Oct; 24(5):297-304. PubMed ID: 25262976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.
    Busch MP; Glynn SA; Wright DJ; Hirschkorn D; Laycock ME; McAuley J; Tu Y; Giachetti C; Gallarda J; Heitman J; Kleinman SH;
    Transfusion; 2005 Dec; 45(12):1853-63. PubMed ID: 16371038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood-donor screening.
    Tobler LH; Stramer SL; Lee SR; Masecar BL; Peterson JE; Davis EA; Andrews WE; Brodsky JP; Kleinman SH; Phelps BH; Busch MP
    Transfusion; 2003 Oct; 43(10):1452-9. PubMed ID: 14507279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical specificity and sensitivity of a blood screening assay for detection of HIV-1 and HCV RNA.
    Vargo J; Smith K; Knott C; Wang S; Fang C; McDonough S; Giachetti C; Caglioti S; Gammon R; Gilbert D; Jackson JB; Richards W; Stramer S; Mimms L
    Transfusion; 2002 Jul; 42(7):876-85. PubMed ID: 12375660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.